Browse > Article

Prevalence of Metabolic Syndrome in Young Korean Women with Polycystic Ovary Syndrome  

Lee, Hye-jin (Departments of Internal Medicine, Ewha Womans University College of Medicine)
Oh, Jee-Young (Departments of Internal Medicine, Ewha Womans University College of Medicine)
Hong, Young-sun (Departments of Internal Medicine, Ewha Womans University College of Medicine)
Sung, Yeon-Ah (Departments of Internal Medicine, Ewha Womans University College of Medicine)
Chung, Hye-won (Departments of Obstetrics and Gynecology, Ewha Womans University College of Medicine)
Publication Information
Diabetes and Metabolism Journal / v.30, no.4, 2006 , pp. 285-291 More about this Journal
Abstract
Background: Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and consequent hyperinsulinemia. Insulin resistance plays an important role in the development of metabolic syndrome (MS). We conducted a cross-sectional study to determine the prevalence of the MS and whether the insulin resistance or hyperandrogenemia is related to the MS in young Korean women with PCOS. Methods: 143 women with PCOS (mean age 26 ${\pm}$ 5 years) were studied to evaluate the prevalence of MS by modified Adult Treatment Panel III. Insulin sensitivity was evaluated by euglycemic hyperinsulinemic clamp technique. Results: The prevalence of MS in women with PCOS was 11.9%, 2.8-fold higher than age matched women in Korean urban population. The most frequent component of MS was low HDL cholesterol (39.4%), and the least frequent one was high fasting serum glucose levels (6.7%). The frequency of MS was 40.7% in obese PCOS (BMI $\geq$ 25 kg/m$^2$, n = 38), 10.0% in overweight PCOS (BMI 23~24.9 kg/m$^2$, n = 13), and 0% in lean PCOS (BMI < 23 kg/m$^2$, n = 92). The frequency of MS was 26.1% in insulin resistant PCOS (insulin mediated glucose uptake, IMGU < lowest 10$^{th}$ percentile of lean controls, n = 65), whereas no one had MS in insulin sensitive PCOS (IMGU $\geq$ lowest 10$^{th}$ percentile of lean controls, n = 78). Conclusion: MS is frequent in young women with PCOS, and obesity and insulin resistance might be essential for the development of MS in this study group.
Keywords
Metabolic syndrome; PCOS;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800, 1997   DOI   ScienceOn
2 Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK: Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-6, 1999   DOI   ScienceOn
3 Reaven GM: Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models. Diabetes Care 14:195-202, 1991   DOI   ScienceOn
4 Haffner SM, D'Agostino R Jr, Festa A, Bergman RN, Mykkanen L, Karter A, Saad MF, Wagenknecht LE: Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors- Diabetes Care 26:2796-803, 2003   DOI   ScienceOn
5 WHO Western Pacific Region, IASO and IOTF: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Australia, Health Communications Australia Pty Limit, 2000
6 Wild S, Pierpoint T, McKeigue P, Jacobs H: Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol 52:595-600, 2000   DOI   ScienceOn
7 Legro RS, Kunselman AR, Dodson WC, Dunaif A: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-9, 1999   DOI
8 Third Report of the National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-421, 2002
9 The Asia-Pacific perspective: Redefining obesity and its treatment [article online], 2000. Available from http://www.diabetes.com.au/downloads/obesity-report.pdf
10 Vermeulen A, Verdonck L, Kaufman JM: A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-72, 1999   DOI
11 Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L: Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52:908-15, 2003   DOI   ScienceOn
12 Rotterdam ESHRE/ASRAM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25, 2004   DOI   ScienceOn
13 Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A: Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 20:2409-13, 2005   DOI   ScienceOn
14 Coviello AD, Legro RS, Dunaif A: Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 91:492-7, 2006   DOI
15 Apridonidze T, Essah PA, Iuorno MJ, Nestler JE: Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929-35, 2005   DOI
16 Vrbikova J, Vondra K, Cibula D, Dvorakova K, Stanicka S, Sramkova D, Sindelka G, Hill M, Bendlova B, Skrha J: Metabolic syndrome in young Czech women with polycystic ovary syndrome. Hum Reprod 20:3328-32, 2005   DOI   ScienceOn
17 Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS: Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-6, 1998   DOI   ScienceOn
18 Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A: Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 160:540-8, 2004   DOI   ScienceOn
19 Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y: Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 274:C1645-52, 1998   DOI
20 Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83: 3078-82, 1998   DOI
21 Nofer JR, van der Giet M, Tolle M, Wolinska I, von Wnuck Lipinski K, Baba HA, Tietge UJ, Godecke A, Ishii I, Kleuser B, Schafers M, Fobker M, Zidek W, Assmann G, Chun J, Levkau B: HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113:569-81, 2004   DOI
22 Oh JY, Hong YS, Sung YA, Barrett-Connor E: Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 27:2027-32, 2004   DOI   ScienceOn
23 Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T: Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 10:1257-66, 1992
24 Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE: Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87:2013-7, 2002   DOI
25 Legro RS, Urbanek M, Kunselman AR, Leiby BE, Dunaif A: Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated. Fertil Steril 78:51-7, 2002   DOI   ScienceOn
26 Korhonen S, Hippelainen M, Vanhala M, Heinonen S, Niskanen L: The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study. Fertil Steril 79:1327-34, 2003   DOI   ScienceOn
27 DeFronzo RA, Tobin JD, and Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-23, 1979
28 Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapandi ED, Bartzis MI: A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84: 4006-11, 1999   DOI